secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2026-10-02T20:32:20+00:00
Accession:  0001213900-26-106429
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

OSR Health Chief Scientific Officer Dr. Constance Hoefer resigns effective Sept 30, 2026
--------------------------------------------------------------------------------

- Dr. Constance Hoefer notified OSR Health of her resignation as Chief Scientific Officer on September 30, 2026; the resignation took immediate effect.
- The company stated the resignation was not the result of any dispute or disagreement with the company on its operations, policies or practices.
- No successor, interim CSO, or transition arrangement was named in the filing.
- 8-K dated October 2, 2026 and signed by Chief Executive Officer Kuk Hyoun Hwang; the same filing lists common stock (OSRH) and warrants (OSRHW) on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026106429/0001213900-26-106429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026106429/ea0307502-8k_osrhealth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-106429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer